OncRef

Clinical Trial: NCT00005584

Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma

Status:

ACTIVE NOT RECRUITING

Phase:

Phase 3

Lead Sponsor:European Organisation for Research and Treatment of Cancer - EORTC
Information Provided By:European Organisation for Research and Treatment of Cancer - EORTC
Last Update Posted:2025-08-05

Study Overview

Brief Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage cancer cells. Combining chemotherapy with radiation therapy may kill more cancer cells. It is not yet known which combination chemotherapy regimen is most effective in treating Hodgkin's lymphoma.

PURPOSE: Randomized phase III trial to compare the effectiveness of different regimens of combination chemotherapy with or without radiation therapy in treating patients who have Hodgkin's lymphoma.

Official Title

Prospective Controlled Trial in Clinical Stages I-II Supradiaphragmatic Hodgkin's Disease: Evaluation of Treatment Efficacy, (Long Term) Toxicity and Quality of Life in Two Different Prognostic Subgroups

Conditions

Lymphoma

Intervention / Treatment

  • Biological: bleomycin sulfate
  • Drug: ABVD regimen
  • Drug: BEACOPP regimen
  • Drug: epirubicin hydrochloride
  • Drug: prednisone
  • Drug: vinblastine sulfate
  • Radiation: radiation therapy

Other Study ID Numbers

  • EORTC-20982
  • FRE-FNCLCC-98014
  • GELA-H9

Start Date (Actual)

1998-10

Primary Completion Date (Actual)

2004-05

Study Completion Date

—

Enrollment (Actual)

1649

Study Type

Interventional

Phase

Phase 3